Reverse T3: The Lab Test That Became a Trend

No thyroid test has grown in popularity as much in recent years as reverse T3, and none is so widely misinterpreted. It usually arrives at the office with a ready-made conclusion: "it's high, so my body isn't converting the hormone, and that's why I'm not getting better." Reverse T3 is real, has a known biological function and has been studied for fifty years — the problem isn't that the test exists, it's what gets done with the result. In this article, every statement comes with the scientific reference that supports it — the full list is at the end.

What it is, in plain language

The thyroid mainly produces T4, which is a storage form. To do its job, that T4 has to be converted — and the body has two possible routes.

It can turn it into T3, the active hormone, the one that actually does the work in the cells. Or it can turn it into reverse T3, a similar molecule that doesn't have T3's effect.

The comparison I use in the office: T4 is an uncut key. The body can cut it to open the lock (T3) or put it away in a drawer (reverse T3).

That choice is made by specific enzymes, which activate or deactivate the hormone depending on what the body needs at the moment (Bianco et al., Endocrine Reviews, 2002; Gereben et al., Endocrine Reviews, 2008).

The key point: producing reverse T3 is not a flaw in the body. It is a mechanism that exists on purpose.

This is nothing new. The daily production and significance of reverse T3 in humans were already established in the 1970s (Chopra, Journal of Clinical Investigation, 1976).

Why it goes up — and why that makes sense

Reverse T3 rises in well-defined situations: acute illness, infection, surgery, hospitalization, prolonged fasting, malnutrition, significant physiological stress.

Notice the pattern. In all of these situations the body is under pressure and needs to conserve. By diverting part of its T4 to the inactive route, it lowers energy expenditure — like cutting back on household spending in a tight month.

This set of changes was described in the medical literature decades ago and is recognized as the body's adaptation to illness, not as a thyroid disease (Wartofsky and Burman, Endocrine Reviews, 1982). In critically ill patients, it is an expected finding (Van den Berghe, Thyroid, 2014).

And there is a practical consequence that is rarely mentioned: in these cases, giving thyroid hormone to "fix" the numbers is not routine practice, because no benefit from doing so has been shown (Fliers et al., The Lancet Diabetes & Endocrinology, 2015).

An abnormal number is a sign that the body has adjusted to something. The job is to find out what — not to erase the signal.

The calculation that became a sales pitch

Here is the heart of the problem.

At some point, the idea caught on of calculating a ratio between T3 and reverse T3 and using that number to decide whether a person "converts well" — and, from there, to justify raising the dose or adding T3 to the treatment.

This practice has not been validated. A review devoted specifically to the subject, with the tongue-in-cheek title "Reverse T3 or perverse T3?", went through forty years of literature and concluded that the test still has no established clinical usefulness for guiding the treatment of hypothyroidism (Gomes-Lima and Burman, Cleveland Clinic Journal of Medicine, 2018).

Guidelines for treating hypothyroidism also do not include it among the tests that guide dose adjustments — monitoring is done with TSH and the patient's clinical evaluation (Jonklaas et al., Thyroid, 2014).

There is no target range for reverse T3 to chase, and no ideal ratio to reach. These numbers were never established because they were never shown to matter.

The honest counterweight: the test is real — the way it's used is not

I need to be precise here, because this article is not against the test.

Reverse T3 is a legitimate measurement, used in research and in specific clinical situations, especially in studying what happens to the thyroid during serious illness. Nothing I've written above says it's made up.

What doesn't hold up is the chain of reasoning built on top of it: measure it, find a high number, conclude there is a conversion block and, based on that, increase the hormone.

And that chain has a cost. Higher hormone doses than necessary are not harmless: excess hormone has known effects on heart rhythm and bone density. Chasing a number that doesn't guide treatment can carry a real price, and that price shows up years later.

The test isn't the problem. The problem is treating a result that was never meant to guide treatment.

So what should be done when the patient still feels unwell?

This is the legitimate question behind every request for a reverse T3 test — and it deserves an answer, not dismissal.

People who seek out this test are almost always in a specific situation: they've been taking levothyroxine, their TSH is back to normal, and the symptoms persist. That situation is real, common and frustrating. It's just that the answer rarely lies in reverse T3.

The path that tends to uncover a real cause:

1. Confirm the treatment is being taken correctly in practice — how you take levothyroxine changes how much of it is absorbed, and there's an entire article on this blog about it.
2. Check ferritin. Low iron stores cause fatigue even without anemia, and this has been shown in a clinical trial.
3. Check B12 and evaluate the stomach when there's reason to.
4. Take a real look at sleep, including snoring and pauses in breathing.
5. Assess mood without embarrassment — depression produces exactly this complaint.
6. Review medications and supplements, which can both affect absorption and skew test results.

It's a less exciting list than a hormone panel. It's also the one that solves the most cases.

The practical mistake that ruins everything

If you take only one thing from this article, let it be this:

Don't accept a dose increase based on reverse T3 alone.

Before changing your hormone dose, ask what hasn't been investigated yet. If the answer is "nothing besides this test," it's worth talking further before changing your treatment.

What to bring to your appointment

• Your previous lab results, including older ones, to compare how things have changed.
• The exact time you take levothyroxine and what you eat or drink around then.
• The complete list of supplements, with the labels.
• A concrete description of the symptom that hasn't improved — which one, since when, and how much it limits you.
• The direct question: which treatable causes of fatigue have already been ruled out in my case?

The takeaway

Reverse T3 is a genuine part of physiology: the way the body slows down when it needs to conserve energy. Measuring it is possible; interpreting it as proof of a conversion block and treating on that basis is what doesn't hold up.

Your body producing reverse T3 is not a defect to be corrected. It's a response to something — and that something is what's worth looking for.

If you still feel unwell with normal labs, your complaint is legitimate and deserves a serious investigation. That is exactly why it shouldn't stop at a test that doesn't point anywhere.

Scientific references

• Chopra IJ. An assessment of daily production and significance of thyroidal secretion of 3,3',5'-triiodothyronine (reverse T3) in man. Journal of Clinical Investigation. 1976;58(1):32-40. PMID: 932209.
• Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews. 2002;23(1):38-89. PMID: 11844744.
• Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocrine Reviews. 2008;29(7):898-938. PMID: 18815314.
• Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocrine Reviews. 1982;3(2):164-217. PMID: 6806085.
• Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456-1465. PMID: 24845024.
• Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. The Lancet Diabetes & Endocrinology. 2015;3(10):816-825. PMID: 26071885.
• Gomes-Lima C, Burman KD. Reverse T3 or perverse T3? Still puzzling after 40 years. Cleveland Clinic Journal of Medicine. 2018;85(6):450-455. PMID: 29883303.
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. PMID: 25266247.